Journal of Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory effects of isoscopoletin on thrombus formation via regulation of cyclic nucleotides in collagen-induced platelets

  • Lee, Dong-Ha (Department of Biomedical Laboratory Science, Namseoul University)
  • Received : 2020.07.23
  • Accepted : 2020.08.24
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

An essential component of the hemostatic process during vascular damage is platelet activation. However, many cardiovascular diseases, such as atherosclerosis, thrombosis, and myocardial infarction, can develop due to excessive platelet activation. Isoscopoletin, found primarily in plant roots of the genus Artemisia or Scopolia, has been studied to demonstrate potential pharmacological effects on Alzheimer's disease and anticancer, but its mechanisms and role in relation to thrombus formation and platelet aggregation have not yet been discovered. This research investigated the effect of isoscopoletin on collagen-induced human platelet activation. As a result, isoscopoletin strongly increased cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in a concentration-dependent manner. In addition, isoscopoletin greatly phosphorylated inositol 1,4,5-triphosphate receptor (IP3R) and vasodilator-stimulated phosphoprotein (VASP), known substrates of cAMP-dependent kinase and cGMP dependent kinase. Phosphorylation of IP3R by isoscopoletin induced Ca2+ inhibition from the dense tubular system Ca2+ channels, and VASP phosphorylation was involved in fibrinogen binding inhibition by inactivating αIIb/β3 in the platelet membrane. Isoscopoletin finally reduced thrombin-induced fibrin clot production and finally reduced thrombus formation. Therefore, this research suggests that isoscopoletin has strong antiplatelet effects and is likely to be helpful for thrombotic diseases involving platelets by acting as a prophylactic and therapeutic agent.

Keywords

References

  1. Schwartz SM, Heimark RL, Majesky MW (1990) Developmental mechanisms underlying pathology of arteries. Physiol Rev 70: 1177-1209 https://doi.org/10.1152/physrev.1990.70.4.1177
  2. Furuichi T, Mikoshiba K (1995) Inositol 1, 4, 5-trisphosphate receptormediated $Ca^{2+}$ signaling in the brain. J Neurochem 64: 953-960 https://doi.org/10.1046/j.1471-4159.1995.64030953.x
  3. Ohkubo S, Nakahata N, Ohizumi Y (1996) Thromboxane A2-mediated shape change: independent of Gq-phospholipase C-$Ca^{2+}$ pathway in rabbit platelets. Br J Pharmacol 117: 1095-1104 https://doi.org/10.1111/j.1476-5381.1996.tb16702.x
  4. Saitoh M, Naka M, Hidaka H (1986) The modulatory role of myosin light chain phosphorylation in human platelet activation. Biochem Biophys Res Commun 140: 280-287 https://doi.org/10.1016/0006-291X(86)91087-9
  5. Cattanco M, Tenconi PM, Lecchi A, Mannucci PM (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res 62: 717-724 https://doi.org/10.1016/0049-3848(91)90375-7
  6. Su CY, Shiao MS, Wang CT (1999) Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem Pharmacol 58: 587-595 https://doi.org/10.1016/S0006-2952(99)00136-7
  7. Quinton TM, Dean WL (1992) Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits $Ca^{2+}$ release from platelet membranes. Biochemical and Biochem Biophys Res Commun 184: 893-899 https://doi.org/10.1016/0006-291X(92)90675-B
  8. Menshikov MYU, Ivanova K, Schaefer M, Drummer C, Gerzer R (1993) Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized $Ca^{2+}$ and on aggregation of human platelets. Eur J Pharmacol 245: 281-284 https://doi.org/10.1016/0922-4106(93)90108-L
  9. Schwarz UR, Walter U, Eigenthaler M (2001) Taming platelets with cyclic nucleotides. Biochem Pharmacol 62: 1153-1161 https://doi.org/10.1016/S0006-2952(01)00760-2
  10. Cavallini L, Coassin M, Borean A, Alexandre A (1996) Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 271: 5545-5551 https://doi.org/10.1074/jbc.271.10.5545
  11. Laurent V, Loisel TP, Harbeck B, Wehman A, Grobe L, Jockusch BM, Frank JW, Gertler,B, Carlier MF (1999) Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. J Cell Biol 144: 1245-1258 https://doi.org/10.1083/jcb.144.6.1245
  12. Sudo T, Ito H, Kimura Y (2003) Phosphorylation of the vasodilatorstimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets 14: 381-390 https://doi.org/10.1080/09537100310001598819
  13. Ali MY, Jannat S, Jung HA, Choi RJ, Roy A, Choi JS (2016) Anti-Alzheimer's disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis. Asian Pac J Trop Med 9(2): 103-111 https://doi.org/10.1016/j.apjtm.2016.01.014
  14. Dong J, Yuan J, Wang JL, Ji RF, Quan QH, Guo XY, Gao J, Liu YG (2017) Study on screening antitumor active fractions and chemical components in active fractions from root of Anaycclus pyrethrum. Zhongguo Zhong Yao Za Zhi 42(20): 3932-3937
  15. Shin JH, Kwon HW, Lee DH (2019) Ginsenoside F4 inhibits platelet aggregation and thrombus formation by dephosphorylation of IP3RI and VASP. J Appl Biol Chem 62: 93100
  16. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of $Ca^{2+}$ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450 https://doi.org/10.1016/S0021-9258(19)83641-4
  17. Berridge MJ, Irvine RF (1989) Inositol phosphates and cell signalling. Nature 341: 197-205 https://doi.org/10.1038/341197a0
  18. Nishikawa M, Tanaka T, Hidaka H (1980) $Ca^{2+}$-calmodulin-dependent phosphorylation and platelet secretion. Nature 287: 863-865 https://doi.org/10.1038/287863a0
  19. Kuo JF, Andersson RG, Wise BC, Mackerlova L, Salomonsson I, Brackett NL, Katoh N, Shoji M, Wrenn RW (1980) Calciumdependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. Proc Natl Acad Sci 77: 7039-7043 https://doi.org/10.1073/pnas.77.12.7039
  20. Wangorsch G, Butt E, Mark R, Hubertus K, Geiger J, Dandekar T, Dittrich M (2011) Time-resolved in silico modeling of finetuned cAMP signaling in platelets: feedback loops, titrated phospho-rylations and pharmacological modulation, BMC Syst Biol 5: 178 https://doi.org/10.1186/1752-0509-5-178
  21. Napenas J, Oost FC, DeGroot A, Loven B, Hong CH, Brennan MT, Lockhart PB, van Diermen DE (2013) Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 115: 491-499 https://doi.org/10.1016/j.oooo.2012.11.001
  22. Topol EJ, Byzova TV, Plow EF (1999) Platelet GPIIb-IIIa blockers. The Lancet 353: 227-231 https://doi.org/10.1016/S0140-6736(98)11086-3
  23. Choi BR, Kim HK, Park JK (2017) Penile erection induced by scoparone from Artemisia capillaris through the nitric oxide-cyclic guanosine monophosphate signaling pathway. World J Mens Health 35: 196-204 https://doi.org/10.5534/wjmh.17023
  24. Wen L, Feil S, Wolters M, Thunemann M, Regler F, Schmidt K, et al., Andreas Friebe A, Olbrich M, Langer H, Gawaz M, de Wit C, Feil R (2018) A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis. Nat Commun. 16: 4301
  25. Gao J, Tao J, Liang W, Zhao M, Du X, Cui S, Duan H, Kan B, Su X, Jiang Z (2015) Identification and characterization of phosphodiesterases that specifically degrade 3'3'-cyclic GMP-AMP. Cell Res 25: 539-550 https://doi.org/10.1038/cr.2015.40
  26. Haslam RJ, Dickinson NT, Jang EK (1999) Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 82: 412-423 https://doi.org/10.1055/s-0037-1615861